Pricing Log in Create free account

Generate Biomedicines, Inc. (GENB) vs Immunocore Holdings PLC Sponsored ADR (IMCR)

Generate Biomedicines, Inc. and Immunocore Holdings PLC Sponsored ADR are both Biotechnology companies. Generate Biomedicines, Inc. and Immunocore Holdings PLC Sponsored ADR are of similar size ($1.6B and $1.6B). Immunocore Holdings PLC Sponsored ADR has the higher net margin (−7.48% vs −1,033.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Immunocore Holdings PLC Sponsored ADR leads on 9 and Generate Biomedicines, Inc. on 6.

Valuation

Metric GENB IMCR Biotechnology median
P/E n/m n/m 11.36
P/S 55.81 3.59 9.12
P/B 3.41 3.67 2.14
Price to free cash flow n/m n/m 26.34
EV/EBITDA n/m n/m 0.62
EV/Sales 41.52 2.52 8.56
Earnings yield (34.76%) (2.13%) (34.18%)
Free cash flow yield (35.71%) (1.18%) (23.62%)

Profitability

Metric GENB IMCR Biotechnology median
Gross margin 100.00% 98.86% 67.24%
Operating margin (1,030.49%) (6.76%) 0.00%
Net margin (1,033.16%) (7.48%) 0.00%
Free cash flow margin (1,412.11%) (4.24%) 0.00%
Return on equity 0.00% (7.87%) (50.28%)
Return on assets (55.72%) (2.88%) (45.89%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GENB IMCR Biotechnology median
Revenue growth (TTM) — 13.10% 6.96%
EPS growth (last fiscal year) (13.66%) 30.39% 29.86%
Revenue growth, 5-year CAGR — 59.57% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GENB IMCR Biotechnology median
Debt to equity 0.00 0.94 0.00
Current ratio 5.01 4.62 4.72
Net debt to EBITDA 0.97 11.19 1.01

Dividend

Metric GENB IMCR Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric GENB IMCR Biotechnology median
Market cap 1.61b 1.57b 167.45m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack